From: Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery
Variables | ERAS-group (n = 61) | Control-group (n = 69) | p - value |
---|---|---|---|
Mean age (years) | 50.7 ± 12.9 | 54.1 ± 9.5 | 0.096 |
Male sex | 47 (77%) | 52 (75%) | 0.813 |
Arterial hypertension | 31 (50.8%) | 35 (51%) | 0.936 |
Hyperlipidemia | 18 (30%) | 11 (16%) | 0.055 |
Diabetes mellitus | 1 (2%) | 7 (9%) | 0.156 |
EuroSCORE II (in %) | 0.837 | 0.774 | 0.416 |
Duration of surgery | 220.7 ± 45.6 | 239.6 ± 59.8 | 0.047 |
Mitral valve surgery | 24 (39%) | 34 (49%) | 0.256 |
Aortic valve surgery | 37 (61%) | 35 (51%) | 0.256 |
Intensive care unit stay (d) | 1.5 ± 1.1 | 2.0 ± 1.9 | 0.035 |
In-hospital stay (d) | 6.1 ± 2.6 | 7.7 ± 3.8 | 0.008 |